Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.
Company Information
About this company
Key people
Wenbin Jiang
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Ming Yan
Co-Founder, Chief Technology Officer, Director
William Mccombe
Chief Financial Officer
Philippe Busque
Senior Vice President, Global Sales and Services
Valerie Barnett
Chief Legal Officer and Corporate Secretary
Deborah J. Neff
Lead Independent Director
Jack T. Ball
Independent Director
Michael Holder
Independent Director
Vera Imper
Independent Director
Click to see more
Key facts
- Shares in issue127.86m
- EPICCTKB
- ISINUS23285D1090
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- Market cap$666.18m
- Employees692
- ExchangeNASDAQ
- IndexS&P 600 Small Cap
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.